Dissecting the Pharmacodynamics and Pharmacokinetics of MSCs to Overcome Limitations in Their Clinical Translation

Recently, mesenchymal stromal stem cells (MSCs) have been proposed as therapeutic agents because of their promising preclinical features and good safety profile. However, their introduction into clinical practice has been associated with a suboptimal therapeutic profile. In this review, we address t...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvadori, Michela, Cesari, Nicola, Murgia, Alba, Puccini, Paola, Riccardi, Benedetta, Dominici, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581775/
https://www.ncbi.nlm.nih.gov/pubmed/31236426
http://dx.doi.org/10.1016/j.omtm.2019.05.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581775/
https://www.ncbi.nlm.nih.gov/pubmed/31236426
http://dx.doi.org/10.1016/j.omtm.2019.05.004

Ejemplares similares